Market Overview:
The global point of care testing for infectious disease market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, growing demand for rapid diagnosis, and technological advancements in point-of-care testing devices. The global point of care testing for infectious disease market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into immunological tests and pathogen nucleic acid tests (PNATs). Immunological tests are further subsegmented into enzyme-linked immunosorbent assay (ELISA), chemiluminescence assay (CLA), fluorescence polarization assay (FPA), and others. The PNATs segment is further subsegmented into polymerase chain reaction (PCR) test kits and transcription mediated amplification test kits. On the basis of application, the market is divided into hospitals, clinics, laboratories/research institutes; academic institutions; pharmaceutical & biotechnology companies; contract research organizations; food & beverage industry; environmental monitoring agencies; other end users such as military establishments & disaster management agencies). Geographically, the global point-of-care testing for infectious disease market has been segmented into North America,, Latin America,, Europe,, Asia Pacific,, Middle East & Africa,.
Product Definition:
Point of care testing for infectious disease is a type of diagnostic test that can be performed in a clinical setting, such as a doctor's office or hospital, rather than in a laboratory. This type of testing allows for the rapid diagnosis of infections, which can help to ensure that patients receive appropriate treatment quickly. Point of care tests are also often less expensive and more convenient than traditional laboratory tests.
Immunological Test:
The global immunological test market is expected to grow at a lucrative rate during the forecast period. The key drivers attributing to its rapid growth include rising prevalence of chronic diseases, increasing demand for home care and Point-of-Care (POC) testing, growing geriatric population base with increased susceptibility towards infectious diseases and unmet need for accurate & efficient diagnostic tests.
Pathogen Nucleic Acid Test:
The global point of care testing market is expected to witness significant growth over the forecast period owing to increasing demand for rapid, accurate & sensitive tests with minimum turnaround time. The growing prevalence of chronic diseases and rising demand for early diagnosis are some major factors driving the market. Furthermore, supportive government initiatives aimed at curbing healthcare-associated infections (HAIs) along with reimbursement policies that encourage early diagnosis will boost the usage rate in this market during the forecast period.
Application Insights:
The others application segment held the largest share of over 70.0% in 2017. The other applications include research settings, home care settings and industrial testing. Increasing demand for point of care tests to screen patients with fever and respiratory symptoms is anticipated to drive this segment over the forecast period as these are common indications of infectious diseases that require immediate medical attention (point of care testing).
Point of care tests have a major role in disease control as they help identify the type, location and severity of an infection at a given time without requiring a full-scale laboratory test. They play an important role in controlling epidemics by enabling quick detection & identification, tracking & monitoring disease trends across different locations thus providing crucial information for formulating effective control measures against infectious diseases at global level (H1B 2018).
Regional Analysis:
North America dominated the global point of care testing market in 2017. This can be attributed to the presence of well-established healthcare infrastructure, high adoption rate for advanced diagnostic technologies, and increasing demand for rapid diagnosis. Moreover, government funding for infectious disease diagnostics is higher in this region as compared to other regions. For instance, according to an article published in Clinical Infectious Diseases Journal (2016), from January 1 st , 2013 to December 31 st , 2015 more than USD X million was awarded by National Institute of Health (NIH) through a research grant program called “Competitive Grants†that encourages researchers and scientists working on infectious diseases throughout the world.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the key growth drivers for the point-of-care testing market for infectious disease. This is because there is an urgent need for accurate and rapid diagnosis to initiate timely treatment.
- Rising demand for portable and easy-to-use diagnostic devices: The growing demand for portable and easy-to-use diagnostic devices is another major factor driving the growth of this market. This is because these devices offer fast, reliable, and accurate results, which are essential in cases of emergency or when time is critical.
- Technological advancements: The advent of new technologies has led to the development of innovative point-of-care testing products that are more sensitive, specific, and user friendly than ever before. This is helping to boost the adoption rate of these products among healthcare professionals worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Point of Care Testing for Infectious Disease Market Research Report
By Type
Immunological Test, Pathogen Nucleic Acid Test
By Application
Hospital, Clinics, Others
By Companies
Abbott, Roche, Siemens, Danaher, Becton, Dickinson, Johnson & Johnson, Instrumentation Laboratory, PTS Diagnostics, Quidel, Sekisui Diagnostics, Nova, EKF Diagnostics, AccuBioTech, Trinity Biotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
143
Number of Tables & Figures
101
Customization Available
Yes, the report can be customized as per your need.
Global Point of Care Testing for Infectious Disease Market Report Segments:
The global Point of Care Testing for Infectious Disease market is segmented on the basis of:
Types
Immunological Test, Pathogen Nucleic Acid Test
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Roche
- Siemens
- Danaher
- Becton, Dickinson
- Johnson & Johnson
- Instrumentation Laboratory
- PTS Diagnostics
- Quidel
- Sekisui Diagnostics
- Nova
- EKF Diagnostics
- AccuBioTech
- Trinity Biotech
Highlights of The Point of Care Testing for Infectious Disease Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immunological Test
- Pathogen Nucleic Acid Test
- By Application:
- Hospital
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Point of Care Testing for Infectious Disease Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Point of care testing for infectious disease is a process where laboratory tests are performed on specimens taken from patients in the clinic or hospital setting. This allows for early detection and treatment of infections, which can save lives.
Some of the major players in the point of care testing for infectious disease market are Abbott, Roche, Siemens, Danaher, Becton, Dickinson, Johnson & Johnson, Instrumentation Laboratory, PTS Diagnostics, Quidel, Sekisui Diagnostics, Nova, EKF Diagnostics, AccuBioTech, Trinity Biotech.
The point of care testing for infectious disease market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Point of Care Testing for Infectious Disease Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Point of Care Testing for Infectious Disease Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Point of Care Testing for Infectious Disease Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Point of Care Testing for Infectious Disease Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Point of Care Testing for Infectious Disease Market Size & Forecast, 2018-2028
4.5.1 Point of Care Testing for Infectious Disease Market Size and Y-o-Y Growth
4.5.2 Point of Care Testing for Infectious Disease Market Absolute $ Opportunity
Chapter 5 Global Point of Care Testing for Infectious Disease Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Point of Care Testing for Infectious Disease Market Size Forecast by Type
5.2.1 Immunological Test
5.2.2 Pathogen Nucleic Acid Test
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Point of Care Testing for Infectious Disease Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Point of Care Testing for Infectious Disease Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Point of Care Testing for Infectious Disease Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Point of Care Testing for Infectious Disease Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Point of Care Testing for Infectious Disease Analysis and Forecast
9.1 Introduction
9.2 North America Point of Care Testing for Infectious Disease Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Point of Care Testing for Infectious Disease Market Size Forecast by Type
9.6.1 Immunological Test
9.6.2 Pathogen Nucleic Acid Test
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Point of Care Testing for Infectious Disease Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Point of Care Testing for Infectious Disease Analysis and Forecast
10.1 Introduction
10.2 Europe Point of Care Testing for Infectious Disease Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Point of Care Testing for Infectious Disease Market Size Forecast by Type
10.6.1 Immunological Test
10.6.2 Pathogen Nucleic Acid Test
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Point of Care Testing for Infectious Disease Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Point of Care Testing for Infectious Disease Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Point of Care Testing for Infectious Disease Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Point of Care Testing for Infectious Disease Market Size Forecast by Type
11.6.1 Immunological Test
11.6.2 Pathogen Nucleic Acid Test
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Point of Care Testing for Infectious Disease Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Point of Care Testing for Infectious Disease Analysis and Forecast
12.1 Introduction
12.2 Latin America Point of Care Testing for Infectious Disease Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Point of Care Testing for Infectious Disease Market Size Forecast by Type
12.6.1 Immunological Test
12.6.2 Pathogen Nucleic Acid Test
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Point of Care Testing for Infectious Disease Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Point of Care Testing for Infectious Disease Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Point of Care Testing for Infectious Disease Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Point of Care Testing for Infectious Disease Market Size Forecast by Type
13.6.1 Immunological Test
13.6.2 Pathogen Nucleic Acid Test
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Point of Care Testing for Infectious Disease Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Point of Care Testing for Infectious Disease Market: Competitive Dashboard
14.2 Global Point of Care Testing for Infectious Disease Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Roche
14.3.3 Siemens
14.3.4 Danaher
14.3.5 Becton, Dickinson
14.3.6 Johnson & Johnson
14.3.7 Instrumentation Laboratory
14.3.8 PTS Diagnostics
14.3.9 Quidel
14.3.10 Sekisui Diagnostics
14.3.11 Nova
14.3.12 EKF Diagnostics
14.3.13 AccuBioTech
14.3.14 Trinity Biotech
